Overview Herceptin is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat metastatic breast cancer in cases where tumors overexpress the HER2 protein and one or more chemotherapy… read more
Overview Herceptin Hylecta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) as an adjuvant treatment for metastatic breast cancer in cases where tumors overexpress the HER2 protein and one… read more
In order to operate the site and better serve you, we collect your data. We also use this data and share with our vendors for the purposes of marketing, research, and monitoring.
Join